Unicycive hit with CRL on oxylanthanum carbonate NDA - The Pharma Letter
10 hours ago • Google News
Charles River Laboratories (CRL)
US$ 135.63-1.5%
Price Chart
Key Statistics
Market Cap
$ 7.45B
P/E Ratio
0.00
Revenue (TTM)
$ 4.02B
Volume
805.09K
52W High
$ 254.15
52W Low
$ 91.86
Dividend Yield
0.00%
Beta
1.48
Technicals
50-Day MA
135.628
200-Day MA
167.3226
52 Week High
254.15
52 Week Low
91.8609
About CRL
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationall.
Employees
18700
Headquarters
Wilmington, MA
CEO
Mr. James C. Foster J.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg